Open access · CC-BY
via OpenAlex
Role of dopamine in the pathophysiology of Parkinson’s disease
Zhidong Zhou, Ling Yi, Dennis Qing Wang, Tit Meng Lim, Eng King Tan
Translational Neurodegeneration · 2023 · ▲ 251 citations
Abstract
A pathological feature of Parkinson's disease (PD) is the progressive loss of dopaminergic neurons and decreased dopamine (DA) content in the substantia nigra pars compacta in PD brains. DA is the neurotransmitter of dopaminergic neurons. Accumulating evidence suggests that DA interacts with environmental and genetic factors to contribute to PD pathophysiology. Disturbances of DA synthesis, storage, transportation and metabolism have been shown to promote neurodegeneration of dopaminergic neurons in various PD models. DA is unstable and can undergo oxidation and metabolism to produce multiple reactive and toxic by-products, including reactive oxygen species, DA quinones, and 3,4-dihydroxyphenylacetaldehyde. Here we summarize and highlight recent discoveries on DA-linked pathophysiologic pathways, and discuss the potential protective and therapeutic strategies to mitigate the complications associated with DA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40035-023-00378-6
- Canonical
- link ↗
- Fetched
- 2026-06-05 MST
Cite this
APA
Zhou, Z., Yi, L., Wang, D.Q., Lim, T.M., & Tan, E.K. (2023). Role of dopamine in the pathophysiology of Parkinson’s disease. <em>Translational Neurodegeneration</em>. https://doi.org/10.1186/s40035-023-00378-6
Vancouver
Zhou Z, Yi L, Wang DQ, Lim TM, Tan EK. Role of dopamine in the pathophysiology of Parkinson’s disease. Translational Neurodegeneration. 2023. doi:10.1186/s40035-023-00378-6.
BibTeX
@article{zhidong2023Roleof,
title = {Role of dopamine in the pathophysiology of Parkinson’s disease},
author = {Zhidong Zhou and Ling Yi and Dennis Qing Wang and Tit Meng Lim and Eng King Tan},
journal = {Translational Neurodegeneration},
year = {2023},
doi = {10.1186/s40035-023-00378-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Neurology 2026
Open access · CC-BY
NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives
Frontiers in neurology 2026
Citation only
NAD<sup>+</sup> signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives.
Pharmacological Research 2024
Open access · CC-BY
Investigating the interplay between mitophagy and diabetic neuropathy: Uncovering the hidden secrets of the disease pathology
Journal of Neuroscience 2016
Open access · CC-BY
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
Biomedicines 2023
Open access · CC-BY
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Cells 2020
Open access · CC-BY